Invention Grant
- Patent Title: Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector
-
Application No.: US14533531Application Date: 2014-11-05
-
Publication No.: US09637524B2Publication Date: 2017-05-02
- Inventor: R. Holland Cheng , Li Xing
- Applicant: The Regents of the University of California
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/005 ; A61K39/21 ; A61K39/29 ; C07K16/10 ; C12N7/00 ; A61K9/51 ; A61K39/12 ; A61K39/00
Abstract:
This invention provides a peptide/nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.
Public/Granted literature
- US20150118319A1 PROTEOLYSIS-RESISTANT CAPSID OF CHIMERIC HEPATITIS E VIRUS AS AN ORAL DELIVERY VECTOR Public/Granted day:2015-04-30
Information query
IPC分类:
